Hayato Yokota
5PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 09, 2026
Drug Interaction Between Erlotinib and Itraconazole in a Patient With Non-Small Cell Lung Cancer.Hayato Yokota, Satoshi Goshima, Yuji Okuda
|Sep 28, 2023
A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and Safety.Tatsuro Fukuhara, Kazuhiro Imai, Taku Nakagawa
|Jul 27, 2023
Effects of polymorphisms in pregnane X receptor and ABC transporters on afatinib in Japanese patients with non-small cell lung cancer: pharmacogenomic-pharmacokinetic and exposure-response analysis.Hayato Yokota, Kazuhiro Sato, Sho Sakamoto
|Oct 23, 2021
Relationship between Plasma Concentrations of Afatinib and the Onset of Diarrhea in Patients with Non-Small Cell Lung Cancer.Hayato Yokota, Kazuhiro Sato, Sho Sakamoto
|May 14, 2020
Effects of STAT3 polymorphisms and pharmacokinetics on the clinical outcomes of gefitinib treatment in patients with EGFR-mutation positive non-small cell lung cancer.Hayato Yokota, Kazuhiro Sato, Sho Sakamoto
Pageof 1
